- Home
- ALHC vs ZLAB Comparison
ALHC vs ZLAB Comparison
Compare ALHC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALHC
- ZLAB
- Stock Information
- Founded
- ALHC 2013
- ZLAB 2013
- Country
- ALHC United States
- ZLAB China
- Employees
- ALHC N/A
- ZLAB N/A
- Industry
- ALHC Medical Specialities
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ALHC Health Care
- ZLAB Health Care
- Exchange
- ALHC Nasdaq
- ZLAB Nasdaq
- Market Cap
- ALHC 3.7B
- ZLAB 3.6B
- IPO Year
- ALHC 2021
- ZLAB 2017
- Fundamental
- Price
- ALHC $13.96
- ZLAB $34.55
- Analyst Decision
- ALHC Buy
- ZLAB Buy
- Analyst Count
- ALHC 11
- ZLAB 4
- Target Price
- ALHC $17.45
- ZLAB $47.37
- AVG Volume (30 Days)
- ALHC 2.9M
- ZLAB 1.0M
- Earning Date
- ALHC 07-31-2025
- ZLAB 08-05-2025
- Dividend Yield
- ALHC N/A
- ZLAB N/A
- EPS Growth
- ALHC N/A
- ZLAB N/A
- EPS
- ALHC N/A
- ZLAB N/A
- Revenue
- ALHC $3,001,892,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- ALHC $43.37
- ZLAB $44.07
- Revenue Next Year
- ALHC $26.55
- ZLAB $49.13
- P/E Ratio
- ALHC N/A
- ZLAB N/A
- Revenue Growth
- ALHC 49.12
- ZLAB 43.72
- 52 Week Low
- ALHC $7.05
- ZLAB $16.01
- 52 Week High
- ALHC $21.06
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ALHC 37.10
- ZLAB 49.05
- Support Level
- ALHC $14.24
- ZLAB $36.36
- Resistance Level
- ALHC $15.73
- ZLAB $44.34
- Average True Range (ATR)
- ALHC 0.61
- ZLAB 1.45
- MACD
- ALHC -0.03
- ZLAB -0.16
- Stochastic Oscillator
- ALHC 13.24
- ZLAB 39.20
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.